Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
about
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@en
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@nl
type
label
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@en
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@nl
prefLabel
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@en
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@nl
P2093
P356
P1476
Lower On-Treatment Low-Density ...... SSEY Phase 3 Alirocumab Trials
@en
P2093
Antonio J Vallejo-Vaz
Christopher P Cannon
Henry N Ginsberg
L Veronica Lee
Laurence Bessac
Michael H Davidson
Robert H Eckel
Robert Pordy
P304
P356
10.1161/JAHA.118.009221
P407
P577
2018-09-01T00:00:00Z